(Total Views: 710)
Posted On: 06/04/2022 2:05:49 PM
Post# of 148878
Re: Goosebumps #124186
Dr. Mazen Noureddin will be presenting 2 posters at ILC 2022; #3410 for TERN-201 (AOC3 protein inhibitor), and #3924 for Leronlimab. Cedars-Sinai has 9 NASH/NAFLD trials at present, with a 10th hopefully in the near future.
(5)
(0)Scroll down for more posts ▼
